Medtecs International Corporation Ltd DRC (9103) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Medtecs International Corporation Ltd DRC (9103) has a cash flow conversion efficiency ratio of 0.027x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$2.80 Million ≈ $88.32K USD) by net assets (NT$102.11 Million ≈ $3.22 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 9103 equity to assets ratio to measure how much of total assets are equity-financed.
Medtecs International Corporation Ltd DRC - Cash Flow Conversion Efficiency Trend (2009–2025)
This chart illustrates how Medtecs International Corporation Ltd DRC's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 9103 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Medtecs International Corporation Ltd DRC Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Medtecs International Corporation Ltd DRC ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Pyxis Oncology Inc
NASDAQ:PYXS
|
-0.193x |
|
Aura Energy Ltd
AU:AEE
|
-0.078x |
|
Peace Acquisition Corp Ordinary Shares
NASDAQ:PECE
|
3.620x |
|
Celxpert Energy
TWO:3323
|
0.025x |
|
Valuence Merger Corp I
NASDAQ:VMCA
|
-0.014x |
|
IBI Lion SOCIMI S.A.
MC:YIBI
|
0.006x |
|
True North Commercial Real Estate Investment Trust
TO:TNT-UN
|
0.042x |
|
Ultralife Corporation
NASDAQ:ULBI
|
0.017x |
Annual Cash Flow Conversion Efficiency for Medtecs International Corporation Ltd DRC (2009–2025)
The table below shows the annual cash flow conversion efficiency of Medtecs International Corporation Ltd DRC from 2009 to 2025. For the full company profile with market capitalisation and key ratios, see Medtecs International Corporation Ltd DR (9103) total market value.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | NT$102.11 Million ≈ $3.22 Million |
NT$-1.88 Million ≈ $-59.09K |
-0.018x | -730.28% |
| 2024-12-31 | NT$107.05 Million ≈ $3.37 Million |
NT$312.00K ≈ $9.83K |
0.003x | +105.29% |
| 2023-12-31 | NT$130.31 Million ≈ $4.11 Million |
NT$-7.18 Million ≈ $-226.37K |
-0.055x | -107.22% |
| 2022-12-31 | NT$152.31 Million ≈ $4.80 Million |
NT$-4.05 Million ≈ $-127.69K |
-0.027x | -116.61% |
| 2021-12-31 | NT$187.91 Million ≈ $5.92 Million |
NT$30.10 Million ≈ $948.44K |
0.160x | -69.33% |
| 2020-12-31 | NT$194.49 Million ≈ $6.13 Million |
NT$101.59 Million ≈ $3.20 Million |
0.522x | +672.04% |
| 2019-12-31 | NT$64.59 Million ≈ $2.03 Million |
NT$4.37 Million ≈ $137.68K |
0.068x | -23.80% |
| 2018-12-31 | NT$63.35 Million ≈ $2.00 Million |
NT$5.62 Million ≈ $177.22K |
0.089x | +136.05% |
| 2017-12-31 | NT$62.92 Million ≈ $1.98 Million |
NT$2.37 Million ≈ $74.57K |
0.038x | -50.48% |
| 2016-12-31 | NT$61.86 Million ≈ $1.95 Million |
NT$4.70 Million ≈ $148.04K |
0.076x | -33.63% |
| 2015-12-31 | NT$60.46 Million ≈ $1.90 Million |
NT$6.92 Million ≈ $218.02K |
0.114x | -27.82% |
| 2014-12-31 | NT$56.24 Million ≈ $1.77 Million |
NT$8.92 Million ≈ $280.97K |
0.159x | +72.61% |
| 2013-12-31 | NT$56.53 Million ≈ $1.78 Million |
NT$5.19 Million ≈ $163.61K |
0.092x | +58.69% |
| 2012-12-31 | NT$56.56 Million ≈ $1.78 Million |
NT$3.27 Million ≈ $103.15K |
0.058x | -62.73% |
| 2011-12-31 | NT$54.60 Million ≈ $1.72 Million |
NT$8.48 Million ≈ $267.23K |
0.155x | +11.36% |
| 2010-12-31 | NT$53.45 Million ≈ $1.68 Million |
NT$7.46 Million ≈ $234.90K |
0.139x | -40.33% |
| 2009-12-31 | NT$50.65 Million ≈ $1.60 Million |
NT$11.84 Million ≈ $373.06K |
0.234x | -- |
About Medtecs International Corporation Ltd DRC
Medtecs International Corporation Limited, an integrated healthcare services provider, manufactures and distributes medical consumables for healthcare distributors, pharmaceutical companies, and hospital groups. It operates through Manufacturing, Hospital, and Distribution and Others segments. The Manufacturing segment produces and sub-contracts a range of medical consumables, including patients'… Read more